bullish
Ship Healthcare Holdings (3360 JP): Continues to Be a Strong Beneficiary of Japan Reopening
234 Views13 Oct 2022 17:21
SUMMARY
- Ship Healthcare Holdings (3360 JP), being a leading supplier of hospital consumables in Japan reported stellar Q1 results, with 7% y/y revenue growth in its medical supply business.
- The impact of COVID-19 is easing in Japan and economic activities are gradually returning to normal. The number of surgeries is recovering due to increasing number of medical consultations.
- Ship Healthcare is expected to report high-single-digit revenue growth in FY23, accelerated from low-single-digit revenue growth reported in FY21 and FY22.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Ship Healthcare Holdings (3360 JP): Continues to Be a Strong Beneficiary of Japan Reopening13 Oct 2022
- Ship Healthcare Holdings (3360 JP): Business Is Set to Revive with Drop in New COVID Cases in Japan22 Dec 2021
x